149 related articles for article (PubMed ID: 17312667)
21. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?
Brunini TM; Mendes-Ribeiro AC; Ellory JC; Mann GE
Cardiovasc Res; 2007 Jan; 73(2):359-67. PubMed ID: 17078937
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
[TBL] [Abstract][Full Text] [Related]
23. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm.
Wilson AM; Harada R; Nair N; Balasubramanian N; Cooke JP
Circulation; 2007 Jul; 116(2):188-95. PubMed ID: 17592080
[TBL] [Abstract][Full Text] [Related]
24. The anabolic effect of arginine on proteins in skin wound and muscle is independent of nitric oxide production.
Zhang XJ; Chinkes DL; Wolfe RR
Clin Nutr; 2008 Aug; 27(4):649-56. PubMed ID: 18316142
[TBL] [Abstract][Full Text] [Related]
25. [Peculiarities of L-arginine metabolism in the blood leukocytes in experimental diabetes mellitus].
Brodiak IV; Sybirna NO
Fiziol Zh (1994); 2008; 54(1):63-8. PubMed ID: 18416186
[TBL] [Abstract][Full Text] [Related]
26. The role of L-arginine following trauma and blood loss.
Loehe F; Bruns CJ; Nitsch SM; Angele MK
Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):80-7. PubMed ID: 17143060
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats.
Shih CD; Chuang YC
Neuroscience; 2007 Nov; 149(3):625-35. PubMed ID: 17916408
[TBL] [Abstract][Full Text] [Related]
28. Myocardial release of nitric oxide during ischaemia and reperfusion: effects of L-arginine and hypercholesterolaemia.
Prasan AM; McCarron HC; Zhang Y; Jeremy RW
Heart Lung Circ; 2007 Aug; 16(4):274-81. PubMed ID: 17420156
[TBL] [Abstract][Full Text] [Related]
29. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
30. [Cardiovascular effects of arginine and nitric oxide].
Faintuch J; Faintuch JJ
Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(6):334-8. PubMed ID: 8731256
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic use of citrulline in cardiovascular disease.
Romero MJ; Platt DH; Caldwell RB; Caldwell RW
Cardiovasc Drug Rev; 2006; 24(3-4):275-90. PubMed ID: 17214603
[TBL] [Abstract][Full Text] [Related]
32. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
[TBL] [Abstract][Full Text] [Related]
33. Effects of L-arginine supplementation on exercise metabolism.
McConell GK
Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):46-51. PubMed ID: 17143054
[TBL] [Abstract][Full Text] [Related]
34. Exogenous arginine in sepsis.
Luiking YC; Deutz NE
Crit Care Med; 2007 Sep; 35(9 Suppl):S557-63. PubMed ID: 17713409
[TBL] [Abstract][Full Text] [Related]
35. Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals.
Siasos G; Tousoulis D; Vlachopoulos C; Antoniades C; Stefanadi E; Ioakeimidis N; Andreou I; Zisimos K; Papavassiliou AG; Stefanadis C
Int J Cardiol; 2008 Jun; 126(3):394-9. PubMed ID: 17588688
[TBL] [Abstract][Full Text] [Related]
36. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
[TBL] [Abstract][Full Text] [Related]
37. Methods using stable isotopes to measure nitric oxide (NO) synthesis in the L-arginine/NO pathway in health and disease.
van Eijk HM; Luiking YC; Deutz NE
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):172-85. PubMed ID: 17049318
[TBL] [Abstract][Full Text] [Related]
38. The clinical pharmacology of L-arginine.
Böger RH; Bode-Böger SM
Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451
[TBL] [Abstract][Full Text] [Related]
39. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants.
Mendoza MG; Castillo-Henkel C; Medina-Santillan R; Jarillo Luna RA; Robles HV; Romo E; Rios A; Escalante B
Nephrology (Carlton); 2008 Jun; 13(3):218-27. PubMed ID: 18315704
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
